Mercator Medical (FRA:MM2) Accumulated Depreciation: €0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MM2 Mercator Medical SA FRA:MM2
60 GF Score
Price €13.36
GF Value €10.70
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Mercator Medical Accumulated Depreciation?

Mercator Medical FRA:MM2 +0.75% 60 Accumulated Depreciation is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:MM2 with a GF Score™ of 60/100 and a GF Value™ of €10.70 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Mercator Medical's quarterly accumulated depreciation increased from Sep. 2025 (€0.0 Mil) to Dec. 2025 (€-52.6 Mil) but then stayed the same from Dec. 2025 (€-52.6 Mil) to Mar. 2026 (€0.0 Mil).

Mercator Medical's annual accumulated depreciation declined from Dec. 2023 (€-58.5 Mil) to Dec. 2024 (€-50.7 Mil) but then increased from Dec. 2024 (€-50.7 Mil) to Dec. 2025 (€-52.6 Mil).

Mercator Medical Accumulated Depreciation Related Terms

Mercator Medical Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Mercator Medical's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical Accumulated Depreciation Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.16 -28.82 -58.53 -50.67 -52.58

Mercator Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -52.58 0.00
FRA:MM2
60GF Score
Mercator Medical SA FRA:MM2
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of €0.0 Mil mean?
Mercator Medical (FRA:MM2) has a Accumulated Depreciation of €0.0 Mil as of Mar. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Mercator Medical and its competitors.
Is Mercator Medical's Accumulated Depreciation too high?
Mercator Medical's current Accumulated Depreciation is €0.0 Mil. Overall, Mercator Medical has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Accumulated Depreciation compare to ISRG and BDX?
Mercator Medical's Accumulated Depreciation of €0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Devices & Instruments company?
A good Accumulated Depreciation depends on the Medical Devices & Instruments industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Mercator Medical and its competitors. Mercator Medical's current Accumulated Depreciation is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Modestly Overvalued. The stock's GF Value™ is €10.70, compared to a current price of €13.36 — trading 24.9% above its estimated fair value. The current Accumulated Depreciation is €0.0 Mil. Mercator Medical's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current Accumulated Depreciation is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (FRA:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued. The current stock price of €13.36 is trading 24.9% above its estimated GF Value™ of €10.70. GuruFocus considers Mercator Medical to be Modestly Overvalued.

Key valuation signals for FRA:MM2:

  • Accumulated Depreciation: €0.0 Mil
  • GF Value™: €10.70 vs. price of €13.36 (24.9% above fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercator Medical Business Description

Other Exchanges MRC:Poland
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
60GF Score

Get the complete analysis for FRA:MM2

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.36
Price
€10.70
GF Value